NM
Neumora Therapeutics, Inc. Common Stock (NMRA)
NASDAQ·Healthcare·Biotechnology
$1.05
-8.33%
Mkt Cap $231.60M
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (14 analysts)
$4.50
Range $4.00 – $5.00
Implied Upside
+330.6%
Consensus $4.50 vs current $1.05